Related Experiment Videos
Regulation of survival signals from the insulin-like growth factor-I receptor
R O'Connor1, C Fennelly, D Krause
1Department of Biochemistry, University College Cork, Lee Maltings, Ireland.
Abstract:
Suppression of apoptosis by survival factors is important for the maintenance of normal tissue homoeostasis and the response to infection or injury. Survival factors such as insulin-like growth factor-I (IGF-I) initiate a signalling cascade that starts by tyrosine phosphorylation of substrates leading to the activation of serine kinases that modulate the activity of members of the Bcl-2 family, which regulates the apoptotic machinery in most cells. Tumour cells often have enhanced survival mechanisms due either to up-regulation of the IGF-I receptor and its ligands or to loss of function of a phosphatase (PTEN) that regulates part of this survival pathway. The C-terminus of the IGF-I receptor appears to be a regulatory domain for the anti-apoptotic activity of this receptor, and certain residues within the C-terminus are essential for this regulatory activity. Knowledge of the proteins and pathways, which interact with these C-terminal domains, should lead us to ways of modulating IGF-I-mediated survival in tumours.
Insights
Survival factors like insulin-like growth factor-I (IGF-I) prevent apoptosis, crucial for tissue health. Understanding IGF-I receptor C-terminus interactions can reveal new cancer survival strategies.
Area of Science:
- Molecular Biology
- Cellular Biology
- Cancer Research
Background:
- Apoptosis suppression by survival factors maintains tissue homeostasis and aids response to injury.
- Insulin-like growth factor-I (IGF-I) signaling cascade involves tyrosine phosphorylation, serine kinases, and Bcl-2 family modulation.
- Tumor cells exploit enhanced survival via IGF-I receptor up-regulation or PTEN phosphatase loss.
Purpose of the Study:
- To investigate the role of the IGF-I receptor C-terminus in regulating anti-apoptotic activity.
- To identify proteins and pathways interacting with the IGF-I receptor C-terminal domains.
- To explore therapeutic strategies for modulating IGF-I-mediated survival in tumors.
Main Methods:
- Analysis of IGF-I receptor signaling pathways.
- Identification of key residues within the C-terminus essential for regulatory activity.
- Investigating protein-protein interactions at the C-terminus.
Main Results:
- The C-terminus of the IGF-I receptor is a critical regulatory domain for its anti-apoptotic function.
- Specific C-terminal residues are essential for mediating the receptor's survival-promoting activity.
- Dysregulation of this pathway, including PTEN loss, contributes to tumor cell survival.
Conclusions:
- Targeting the IGF-I receptor C-terminus offers potential for novel cancer therapies.
- Understanding C-terminal interactions can lead to strategies to inhibit tumor cell survival.
- Modulating IGF-I-mediated survival pathways is a promising avenue for cancer treatment.